SIGA Technologies Inc
Closed
SectorHealthcare
4.3 -0.69
Overview
Share price change
24h
Min
4.27
Max
4.33
Income | -34M -3.5M |
|---|---|
Sales | 2.4M 6.2M |
P/E Sector Avg | 15.464 49.052 |
EPS | -0.048 |
Profit margin | -55.334 |
Employees | 49 |
EBITDA | 4.3M -5.2M |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | -22M 311M |
|---|---|
Previous open | 4.99 |
Previous close | 4.3 |
News Sentiment
By Acuity
89%
11%
323 / 342 Healthcare
SIGA Technologies Inc Chart
Past performance is not a reliable indicator of future results.
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
